Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
- Conditions
- Non-valvular Atrial Fibrillation
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Laminar, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT05565599
- Locations
- 🇺🇸
Tucson Medical Center, Tucson, Arizona, United States
🇺🇸St. Bernards Medical Center, Jonesboro, Arkansas, United States
🇺🇸Scripps Health, La Jolla, California, United States
A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Laminar, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT05224375
- Locations
- 🇬🇪
Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2021-03-19
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Laminar, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT04807283
- Locations
- 🇬🇪
Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Georgia
🇬🇪Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
🇵🇾Sanatorio Italiano Hospital, Asunción, Paraguay